Bram Vanparys, Gimv managing partner, head of life sciences

Long-time health­care in­vestor looks to dou­ble num­ber of life sci­ences star­tups in its 'ev­er­green' fund

Hav­ing con­sis­tent­ly kept about a dozen life sci­ences com­pa­nies in its port­fo­lio over the past few decades, Eu­ro­pean in­vestor Gimv is ready to dou­ble down — quite lit­er­al­ly.

The Brus­sels-based firm is adding life sci­ences as a fifth plat­form, along­side con­sumer, health­care, smart in­dus­try and sus­tain­able cities, with the goal of grow­ing the num­ber of backed com­pa­nies to 20.

Be­cause Gimv is a list­ed com­pa­ny on its own and runs on an ever­green struc­ture, it’s hard to pin down an ex­act fig­ure, as with oth­er VCs op­er­at­ing closed end funds, said Bram Van­parys, who’s new­ly ap­point­ed man­ag­ing part­ner, head of life sci­ences.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.